Shukla et al. found an upregulation of glycolysis by increased MUC1 expression in Gemcitabine-resistant pancreatic cancer cells causing a stabilization of HIF-1α resulting in turn in a higher dependency on glucose and an increased dNTP production [76,77]. Here, MUC1 is linked to familial pancreatic carcinoma.